QUINCE Trademark

Trademark Overview


On Wednesday, April 27, 2022, a trademark application was filed for QUINCE with the United States Patent and Trademark Office. The USPTO has given the QUINCE trademark a serial number of 97385224. The federal status of this trademark filing is REGISTERED as of Tuesday, May 20, 2025. This trademark is owned by Cortexyme, Inc.. The QUINCE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical, medicinal and biological preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease, autoimmune disease, inflammatory disease, diabetes, cardiovascular disease, cancer, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders

Medical and scientific research; pharmaceutical research and development; pharmaceutical and biological research; pharmaceutical testing; pharmaceutical product development consultation; scientific research in the nature of conducting clinical trials for others in the fields of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease, autoimmune disease, inflammatory disease, diabetes, cardiovascular disease, cancer, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
quince

General Information


Serial Number97385224
Word MarkQUINCE
Filing DateWednesday, April 27, 2022
Status700 - REGISTERED
Status DateTuesday, May 20, 2025
Registration Number7803872
Registration DateTuesday, May 20, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2023

Trademark Statements


Goods and ServicesPharmaceutical, medicinal and biological preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease, autoimmune disease, inflammatory disease, diabetes, cardiovascular disease, cancer, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Goods and ServicesMedical and scientific research; pharmaceutical research and development; pharmaceutical and biological research; pharmaceutical testing; pharmaceutical product development consultation; scientific research in the nature of conducting clinical trials for others in the fields of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease, autoimmune disease, inflammatory disease, diabetes, cardiovascular disease, cancer, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code005
First Use Anywhere DateThursday, September 26, 2024
First Use In Commerce DateThursday, September 26, 2024

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code042
First Use Anywhere DateThursday, September 26, 2024
First Use In Commerce DateThursday, September 26, 2024

Trademark Owner History


Party NameQUINCE THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameQUINCE THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameQUINCE THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080

Party NameCortexyme, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Tuesday, February 14, 2023ASSIGNED TO EXAMINER
Saturday, April 30, 2022NEW APPLICATION ENTERED
Tuesday, May 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 26, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 21, 2023NON-FINAL ACTION WRITTEN
Tuesday, February 21, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 24, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 13, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 13, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 8, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 17, 2024SOU EXTENSION 1 FILED
Wednesday, January 17, 2024SOU EXTENSION 1 GRANTED
Wednesday, January 17, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 27, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, June 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 27, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 27, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 1, 2024SOU EXTENSION 2 GRANTED
Thursday, August 1, 2024SOU EXTENSION 2 FILED
Monday, September 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 4, 2025SOU TEAS EXTENSION RECEIVED
Monday, September 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 4, 2025USE AMENDMENT FILED
Tuesday, February 4, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, February 4, 2025SOU EXTENSION 3 FILED
Tuesday, February 4, 2025SOU EXTENSION 3 GRANTED
Wednesday, February 5, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 14, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, April 14, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 28, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 28, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 20, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, May 20, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED